| ¿µ¹® | parenteral administration of drugs | ÇÑ±Û | ºñ°æ±¸Àû ¾àǰÅõ¿© |
|---|---|---|---|
| ¼³¸í | ÀÔÀ» ÅëÇÏÁö ¾Ê´Â ´Ù¾çÇÑ ¾àǰÅõ¿© ¹æ¹ýÀ» ¸»ÇÔ. ÁÖ»ç±â¸¦ ÀÌ¿ëÇÑ´Ù. 1)ÇÇÇÏÁÖ»ç: subcutaneous injection-ÇǺΠ¹ØÀ¸·Î ÁÖ»çÇÏ´Â °Í. ´ë°³ ÆÈÀÇ Áß°£ºÎ¿¡ ÁÖ»çÇÑ´Ù. 2)ÁøÇdz»ÁÖ»ç: intradermal injection-¾ã°Ô Âñ·¯¼ ÁøÇdz»¿¡ ÁÖ»çÇÑ´Ù. ÁÖ·Î ¾Ë·¯Áö ȯÀÚÀÇ Ç׿ø°Ë»ç¿¡ ÀÌ¿ëÇÑ´Ù. 3)±ÙÀ°³»ÁÖ»ç: intramuscular injection-À§ÆÈÀ̳ª, ȤÀº ¾ûµ¢ÀÌ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. À̰ÍÀº ÁÖ·Î ÇǺο¡ ÀÚ±ØÀÌ ½ÉÇÑ ¾àÁ¦³ª ȤÀº õõÈ÷ ÀÛ¿ëÇÏ´Â ¾àÁ¦¸¦ ¸¹ÀÌ ÁÖ»çÇÒ ¶§ »ç¿ëÇÑ´Ù. 4)Ç÷°üÁÖ»ç: intravenous(IV) injection-Á¤¸ÆÀ» ÅëÇØ ÁÖ»çÇÑ´Ù. ¾î´À Á¤¸ÆÀ̳ª °¡´ÉÇÏÁö¸¸, ´ë°³ ÆÈ¶ÒÀ̳ª ¹ß µîÀÇ Á¤¸ÆÀ» ÀÌ¿ëÇÑ´Ù. ºü¸¥ Ä¡·áÈ¿°ú¸¦ º¸±â À§ÇØ »ç¿ëÇÑ´Ù. À̶§ ÇǺο¡ ÀÚ±ØÀ» ÁÖ´Â ¾àÁ¦À̸é, »õÁö ¾Êµµ·Ï Á¶½ÉÇØ¾ß ÇÑ´Ù. 5) ¼ö¸·°³»ÁÖ»ç: intrathecal injection-µÎ°³³ª ô¼ö°³»¿¡ ÁÖ»çÇÒ ¶§ ÀÌ¿ëÇÑ´Ù. 6)°³»ÁÖ»ç: intracavitary injection-°ø°£À¸·Î µÈ ºÎÀ§¿¡ ÁÖ»çÇÑ´Ù. ¿¹¸¦ µé¾î º¹ºÎ°ø°£À̳ª Èä°³»¿¡ ÁÖ»çÇÏ¿© »ç¿ëÇÑ´Ù. |
||
| ¿µ¹® | total lung capacity | ÇÑ±Û | ÀüÆó¿ë·®, ¿ÂÇãÆÄ¿ë·® |
|---|---|---|---|
| ¼³¸í | ÆóȰ·®(°¡´ÉÇÑ ÇÑ ±í°Ô µé¿© ¸¶½Å ½ÃÁ¡ºÎÅÍ ÃµÃµÈ÷ ÇѲ¯ ³»½® ¿ë·®)¿¡ Àܱⷮ(ÃÖ´ë ³¯¼ûÀ§Ä¡¿¡¼ Æó³»¿¡ ³²Àº ¿ë·®. ¾à 1,200mL)À» ÇÕÇÑ °ÍÀÌ´Ù. °Ç°ÇÑ ¼ºÀÎÀº 6,000~7,000mL. Æó±âÁ¾, ¸¸¼º ±â°üÁö¿° µîÀÇ Æó»ö¼º Àå¾Ö·Î Áõ°¡ÇÏ°Ô µÇ´Â ÇÑÆí ÇãÆÄ¼¶À¯Áõ, ¹«±âÆó, Èä¼ö, Èä°ûº¯Çü µîÀÇ ±¸¼Ó¼º Àå¾Ö·Î °¨¼ÒÇÑ´Ù. |
||
| TPA | tannic acid, polyphosphomolybdic acid, and amino acid; 12-0-tetradecanoyl-phorbol-13-acetate; third-... |
|---|---|
| TC | target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin... |
| TBS | total body solids; total body solute; total body surface; total burn size; Townes-Brocks syndrome; t... |
| TLC | tender loving care; thin-layer chromatography; total L-chain concentration; total lung capacity; tot... |
| EA | early antigen; educational age; egg albumin; electric affinity; electrical activity; electroacupunct... |
| TPN | Total parenteral nutrient |
|---|---|
| HPN | Home Parenteral Nutrition |
| IDPN | Intradialytic parenteral nutrition |
| OPAT | Outpatient parenteral antibiotic therapy |
| PN | Parenteral Nutrition |
| parenteral nutrition, home total | The at-home administering of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously or by some other non-alimentary route. (12 Dec 1998) |
|---|---|
| parenteral nutrition, total | The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of tpn solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins. (12 Dec 1998) |
| total parenteral nutrition | <pharmacology> Intravenous feeding that provides patients with all essential nutrients when they are unable to feed themselves. Acronym: TPN (12 Jan 1998) |
| alimentation | To provide nourishment, feeding (27 Sep 1997) |
| forced alimentation | Giving liquid food through a nasal tube passed into the stomach, forcing a person to eat more food than desired. Synonym: forced alimentation. (05 Mar 2000) |
| parenteral | <pharmacology> Not through the alimentary canal but rather by injection through some other route, as subcutaneous, intramuscular, intraorbital, intracapsular, intraspinal, intrasternal, intravenous, etc. Origin: Gr. Enteron = intestine (18 Nov 1997) |
| parenteral absorption | Absorption by any route other than the alimentary tract. (05 Mar 2000) |
| parenteral nutrition | <gastroenterology, pharmacology> A method of delivering nutrition or other substances directly into a vein. Fluids given usually include salt (saline), glucose, amino acids, electrolytes, vitamins and medications. (16 Dec 1997) |
| parenteral nutrition, home | The at-home administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered via a route other than the alimentary canal (e.g., intravenously, subcutaneously). (12 Dec 1998) |
| parenteral therapy | Therapy introduced usually by a needle through some other route than the alimentary canal. (05 Mar 2000) |
| infusions, parenteral | The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. (12 Dec 1998) |
| radical mastectomy, total | Breast cancer treatment involving removal of the breast, the pectoral (chest) muscles, lymph nodes (the glands ) in the armpit and associated skin and subcutaneous tissue. (12 Dec 1998) |
| reversal of organs, total | This condition (medically called situs inversus totalis) involves complete transposition (right to left reversal) of the thoracic and abdominal organs. The heart is not in its usual position in the left chest but is on the right. Specifically related to the heart, this is referred to as dextrocardia (literally, right-hearted). And the stomach, which is normally in the left upper abdomen, is on the right. In patients with situs inversus totalis, all of the chest and abdominal organs are reversed and appear in mirror image when examined or visualised by tests such as X-ray filming. Situs inversus totalis has been estimated to occur once in about 6-8,000 births. Situs inversus occurs in a rare abnormal condition that is present at birth (congenital) called kartagener's syndrome. (12 Dec 1998) |
| communication methods, total | Utilization of all available receptive and expressive modes for the purpose of achieving communication with the hearing impaired, such as gestures, postures, facial expression, types of voice, formal speech and non-speech systems, and simultaneous communication. (12 Dec 1998) |
| congenital total lipodystrophy | Lipodystrophy characterised by almost complete lack of subcutaneous fat, accelerated rate of growth and skeletal development during the first 3 to 4 years of life, muscular hypertrophy, cardiac enlargement, hepatosplenomegaly, hypertrichosis, renal enlargement, hypertriglyceridemia, and hypermetabolism; both autosomal dominant and X-linked varieties exist. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|